Pricing Log in Create free account

CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs Curis, Inc. (CRIS)

CollPlant Biotechnologies Ltd. Sponsored ADR and Curis, Inc. are both Biotechnology companies. CollPlant Biotechnologies Ltd. Sponsored ADR is the larger, with a market value of $7.5M against $5.7M — 1.3× the size. Curis, Inc. grew revenue faster over the last twelve months: −13.4% against −86.8%. Curis, Inc. has the higher net margin (0.00% vs −3,934.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Curis, Inc. leads on 12 and CollPlant Biotechnologies Ltd. Sponsored ADR on 4.

Valuation

Metric CLGN CRIS Biotechnology median
P/E n/m n/m 10.26
P/S 18.24 0.20 9.18
P/B 1.97 0.40 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.29 0.65
EV/Sales 26.12 (0.27) 8.98
Earnings yield (235.64%) (1,634.48%) (34.89%)
Free cash flow yield (193.83%) (1,668.41%) (24.52%)

Profitability

Metric CLGN CRIS Biotechnology median
Gross margin (321.70%) 99.52% 65.16%
Operating margin (3,900.94%) 0.00% 0.00%
Net margin (3,934.91%) 0.00% 0.00%
Free cash flow margin (3,522.64%) 0.00% 0.00%
Return on equity (161.98%) 455.35% (50.12%)
Return on assets (101.59%) (87.76%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLGN CRIS Biotechnology median
Revenue growth (TTM) (86.76%) (13.43%) 6.26%
EPS growth (last fiscal year) 35.17% 91.57% 29.88%
Revenue growth, 5-year CAGR (17.32%) (2.71%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN CRIS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.57 0.49 4.89
Net debt to EBITDA 0.56 0.91 1.01

Dividend

Metric CLGN CRIS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLGN CRIS Biotechnology median
Market cap 7.45m 5.67m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack